Stay updated on Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel
Sign up to get notified when there's something new on the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page.

Latest updates to the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.4.3 was deployed, replacing v3.4.2. This appears to be a minor maintenance update with no visible changes to the study details on the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.2 is now shown in the page footer, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedFooter Revision label updated from v3.4.0 to v3.4.1. This is a minor maintenance update with no impact on study details or site navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a glossary toggle and updated QC metadata to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous capitalization and version text.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no substantive changes to the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check88 days agoChange DetectedLocations were updated with many new sites across multiple countries and regions and some sites were removed, changing where eligible participants can enroll.SummaryDifference2%

Stay in the know with updates to Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel
Enter your email address, and we'll notify you when there's something new on the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page.